FDA authorizes wider use of new oral medication for AIDS.
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications*; D000284:Administration, Oral; D053626:Atovaquone; D015507:Drugs, Investigational; D006801:Humans; D009285:Naphthoquinones / Q000008:administration & dosage*; D011020:Pneumonia, Pneumocystis / Q000150:complications / Q000188:drug therapy*
D015507:Drugs, Investigational; D009285:Naphthoquinones; D053626:Atovaquone